Areas of Focus
CGI is dedicated to provide innovative diagnostic assays and products to the clinical oncology community to empower personalized disease management. Products being developed and commercialized at CGI are poised to transform cancer patient management, increase treatment efficacy, and reduce healthcare costs. CGI’s research focuses on the development of tests applicable to the detection of genomic abnormalities in cancer. To achieve this goal, CGI has developed two categories of genomic products that are being used in the clinical setting to inform and transform cancer treatment – DNA-FISH Probes and CGH Microarrays.
- CGI’s FISH-based tests are panels of individual DNA-FISH Probes designed to maximize the ability to detect, monitor and inform treatment of specific cancers. For further information, please go to www.cancergeneticsitalia.com.
- CGH Microarrays are designed for the global interrogation of genomic abnormalities with clinical relevance to cancer. It is expected that new cancer biomarkers will also be discovered during these research efforts.
